SAR-CoV-2 vaccine (Sichuan University/Zhejiang Teruisi Pharmaceutical/Chengdu Institute of Biological Products)

N/A

Report date: 2025/01/26 15:17:35

Base Information

Drug NameSAR-CoV-2 vaccine (Sichuan University/Zhejiang Teruisi Pharmaceutical/Chengdu Institute of Biological Products)
Drug Alias Namerecombinant protein vaccine (Sichuan University/Zhejiang Teruisi Pharmaceutical/Chengdu Institute of Biological Products)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Teruisi Pharmaceutical IncSichuan UniversityChengdu Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A